Anticancer, or antineoplastic, drugs are used to treat malignancies, cancerous growths. Drug therapy may be
Anticancer drugs are used to control the growth of cancerous cells. Cancer is commonly defined as the uncontrolled growth of cells, with loss of differentiation and commonly, with metastasis, spread of the cancer to other tissues and organs. Cancers are malignant growths. In contrast, benign growths remain encapsulated and grow within a well-defined area. Although benign tumors may be fatal if untreated, due to pressure on essential organs, as in the case of a benign brain tumor, surgery or radiation are the preferred methods of treating growths which have a well defined location. Drug therapy is used when the tumor has spread, or may spread, to all areas of the body.
Several classes of drugs may be used in cancer treatment, depending on the nature of the organ involved. For example, breast cancers are commonly stimulated by estrogens, and may be treated with drugs which inactive the sex hormones. Similarly, prostate cancer may be treated with drugs that inactivate androgens, the male sex hormone. However, the majority of antineoplastic drugs act by interfering with cell growth. Since cancerous cells grow more rapidly than other cells, the drugs target those cells which are in the process of reproducing themselves. As a result, antineoplastic drugs will commonly affect not only the cancerous cells, but others cells that commonly reproduce quickly, including hair follicles, ovaries and testis, and the blood-forming organs.
Newer approaches to antineoplastic drug therapy have taken different approaches, including angigenesis— the inhibition of formation of blood vessels feeding the tumor and contributing to tumor growth. Although these approaches hold promise, they are not yet in common use.
Antineoplastic drugs may be divided into two classes: cycle specific and non-cycle specific. Cycle specific drugs act only at specific points of the cell's duplication cycle, such as anaphase or metaphase, while non-cycle specific drugs may act at any point in the cell cycle. In order to gain maximum effect, antineoplastic drugs are commonly used in combinations.
Because antineoplastic agents do not target specific cell types, they have a number of common adverse side effects. Hair loss is common due to the effects on hair follicles, and anemia, immune system impairment, and clotting problems are caused by destruction of the blood forming organs, leading to reduction in the number of red cells, white cells, and platelets. Because of the frequency and severity of these side effects, it is common to administer chemotherapy in cycles, allowing time for recovery from the drug effects before administering the next dose. Doses are often calculated, not on the basis of weight, but rather based on blood counts, in order to avoid dangerous levels of anemia (red cell depletion), neutropenia (white cell deficiency), or thrombocytopenia (platelet deficiency).
Nausea and vomiting are among the most common adverse effects of cancer chemotherapy, and in some cases may be severe enough to cause dose reduction or discontinuation of treatment. The health professional has many responsibilities in dealing with patients undergoing chemotherapy. The patient must be well informed of the risks and benefits of chemotherapy, and must be emotionally prepared for the side effects. These may be permanent, and younger patients should be aware of the high risk of sterility after chemotherapy.
The patient must also know which side effects should be reported to the practitioner, since many adverse effects do not appear until several days after a dose of chemotherapy. When chemotherapy is self-administered, the patient must be familiar with proper use of the drugs, including dose scheduling and avoidance of drug-drug and food-drug interactions.
Appropriate steps should be taken to minimize side effects. These may include administration of antinauseant medications to reduce nausea and vomiting, maintaining fluid levels to reduce drug toxicity, particularly to the kidneys, or application of a scalp tourniquet to reduce blood flow to the scalp and minimize hair loss due to drug therapy.
Patients receiving chemotherapy are also at risk of infections due to reduced white blood counts. While prophylactic antibiotics may be useful, the health care professional should also be sure to use standard precautions, including gowns and gloves when appropriate. Patients should be alerted to avoid risks of viral contamination, and live virus immunizations are contraindicated until the patient has fully recovered from the effects of chemotherapy. Similarly, the patient should avoid contact with other people who have recently had live virus immunizations.
Other precautions which should be emphasized are the risks to pregnant or nursing women. Because antineoplastic drugs are commonly harmful to the fetus, women of childbearing potential should be cautioned to
| ANTI CANCER DRUGS | |||
| Generic (Brand Name) | Clinical Uses | Common Side Effects To Drug | |
| Altretamine (Hexalen) | Treatment of advanced ovarian cancer | Bone marrow depression, nausea and vomiting | |
| Asparaginase (Elspar) | Commonly used in combination with other drugs; refractory acute lymphocytic leukemia | Liver, kidney, pancreas, CNS abnormalities, | |
| Bleomycin (Blenoxane) | Lymphomas, Hodgkin's disease, testicular cancer | Hair loss, stomatitis, pulmonary toxicity, hyperpigmentation of skin | |
| Busulfan (Myleran) | Chronic granulocytic leukemia | Bone marrow depression, pulmonary toxicity | |
| Carboplatin (Paraplatin) | Pallilation of ovarian cancer | Bone marrow depression, nausea and vomiting | |
| Carmustine | Hodgkin's disease, brain tumors, multiple myeloma, malignant melonoma | Bone marrow depression, nausea and vomiting, toxic damage to liver | |
| Chlorambucil (Leukeran) | Chronic lymphocytic leukemia, non-Hodgkin's lymphomas, breast and ovarian cancer | Bone marrow depression, excess uric acid in blood | |
| Cisplatin (Platinol) | Treatment of bladder, ovarian, uterine, testicular, head and neck cancers | Renal toxicity and ototoxicity | |
| Cladribine (Leustatin) | Hairy cell leukemia | Bone marrow depression, nausea and vomiting, fever | |
| Cyclophosphamide (Cytoxan) | Hodgkin's disease, non-Hodgkin's lymphomas, neuroblastoma. Often used with other drugs for breast, ovarian, and lung cancers; acute lymphoblastic leukemia in children; multiple myeloma | Bone marrow depression, hair loss, nausea and vomiting, inflammation of the bladder | |
| Cytarabine (Cytosar-U) | Leukemias occurring in adults and children | Bone marrow depression, nausea and vomiting, diarrhea, stomatitis | |
| Dacarbazine (DTIC-Dome) | Hodgkin's disease, malignant melanoma | Bone marrow depression, nausea and vomiting | |
| Diethylstilbestrol (DES) (Stilbestrol) | Breast cancer in post-menopausal women, prostate cancer | Hair loss, nausea and vomiting, edema, excess calcium in blood; feminizing effects in men | |
| Ethinyl estradiol (Estinyl) | Advanced breast cancer in post-menopausal women, prostate cancer | Excess calcium in blood, anorexia, edema, nausea and vomiting; feminizing effects in men | |
| Etoposide (VePesid) | Acute leukemias, lymphomas, testicular cancer | Bone marrow depression, nausea and vomiting, hair loss | |
| ANTI CANCER DRUGS (continued) | ||
| Generic (Brand Name) | Clinical Uses | Common Side Effects To Drug |
| Floxuridine (FUDR) | Cancers of the liver, pancreas, GI and biliary tract, head and neck tumors | See Cytarabine |
| Fludarabine(Fludara) | Chronic lymphocytic leukemia | Bone marrow depression, nausea and vomiting, fever |
| Fluorouracil (5-FU) (Adrucil) | Breast, colon, pancreatic cancer, cancer of the rectum and stomach | See Cytarabine |
| Flutamide (Eulexin) | Advanced prostate cancer | Nausea and vomiting, hot flashes, diarrhea, impotence, decreased libido, gynecomastia |
| Goserelin (Zoladex) | Advanced prostate cancer | Pain in bones |
| Hydroxyurea (Hydrea) | Chronic granulocytic leukemia, malignant melanoma | Bone marrow depression, gastrointestinal irritation |
| Idarubicin (Idamycin) | Used in combination with other antileukemic drugs, acute myelogenous leukemia | See Doxorubicin |
| Ifosfamide (Ifex) | Germ cell testicular cancer | Bone marrow depression, nausea and vomiting, inflammation of the bladder |
| Leuprolide (Lupron) | Advanced prostate cancer | See Goserelin |
| Levamisole (Ergamisol) | Used in conjunction with Fluorouracil to treat colon cancer | Diarrhea, dermatitis, nausea and vomiting |
| Lomustine | Brain tumors, Hodgkin's disease | Bone marrow depression, nausea and and vomiting, toxic damage to liver |
| Mechlorethamine (Mustargen) | Lung cancer, Hodgkin's disease and non-Hodgkin's lymphomas | Bone marrow depression, nausea and vomiting |
| Medroxyprogesterone (Depo-Provera) | Advanced uterine cancer | May cause edema |
| Megestrol (Megace) | Advanced uterine cancer, breast cancer | Masculinizing effects |
| Melphalan (Alkeran) | Multiple myeloma | Bone marrow depression, nausea and vomiting |
| Mercaptopurine (Purinethol) | Acute and chronic leukemias | Bone marrow depression, nausea, excess uric acid in blood |
| Methotrexate (Mexate) | Acute lymphoblastic leukemias in children, bone cancer, choriocaricinoma of the testes | Bone marrow depression, diarrhea, nausea, stomatitis |
| ANTI CANCER DRUGS (continued) | ||
| Generic (Brand Name) | Clinical Uses | Common Side Effects To Drug |
| Mitomycin (Mutamycin) | Bladder, breast, colon, lung, pancreas, rectum cancers, head and neck cancer, malignant melanoma | Bone marrow depression, nausea and vomiting, diarrhea, stomatitis, possible tissue damage |
| Mitotane (Lysodren) | Cancer of the adrenal cortex (inoperable) | Damage to adrenal cortex, nausea, anorexia |
| Mitoxantrone (Novantrone) | Acute nonlymphocytic leukemia | Cardiac arrhythmias, labored breathing, nausea and vomiting, diarrhea, fever, congestive heart failure |
| Paclitaxel (Taxol) | Advanced ovarian cancer | Bone marrow depression, hair loss, nausea and vomiting, hypotension, allergic reactions, slow heart action, muscle and joint pain |
| Pentastatin (Nipent) | Hairy cell leukemia unresponsive to alpha-interferon | Bone marrow depression, fever, skin rash, liver damage, nausea and vomiting |
| Pipobroman (Vercyte) | Chronic granulocytic leukemia | Bone marrow depression |
| Plicamycin (Mithracin) | Testucular tumors | Toxicity/damage to bone marrow, kidneys, and liver |
| Prednisone (Meticorten) | Used in adjunct therapy for palliation of symptoms in lymphomas, acute leukemia, Hodgkin's disease | May be toxic to all body systems |
| Procarbazine (Matulane) | Hodgkin's disease | Bone marrow depression, nausea and vomiting |
| Streptozocin (Zanosar) | Islet cell carcinoma of pancreas | Nausea and vomiting, toxicity to kidneys |
| Tamoxifen (Nolvadex) | Advanced breast cancer in post menopausal | Nausea and vomiting, ocular toxicity, hot flashes |
| Teniposide (Vumon) | Acute lymphocytic leukemia in children | See Etoposide |
| Vinblastine (Velban) | Breast cancer, Hodgkin's disease, metastatic testicular cancer | Bone marrow depression, neuro-toxicity |
| Vincristine (Oncovin) | Acute leukemia, Hodgkin's disease, lymphomas | Constipation, neurotoxicity, possible tissue necrosis |
use two effective methods of birth control while receiving cancer chemotherapy. This also applies if the woman's male partner is receiving chemotherapy. Breastfeeding should be avoided while the mother is being treated.
Before prescribing or administering anticancer drugs, health care providers should inquire whether the patient has any of the following conditions:
|
|
Author Info: Samuel Uretsky PharmD, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Nursing and Allied Health, 2002 |